Charles River Laboratories International, Inc. Stock
Equities
CRL
US1598641074
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
232.6 USD | -0.11% | -1.16% | -1.62% |
Sales 2024 * | 4.22B 5.74B | Sales 2025 * | 4.53B 6.16B | Capitalization | 11.98B 16.3B |
---|---|---|---|---|---|
Net income 2024 * | 406M 553M | Net income 2025 * | 513M 698M | EV / Sales 2024 * | 3.3 x |
Net Debt 2024 * | 1.94B 2.65B | Net Debt 2025 * | 1.46B 1.98B | EV / Sales 2025 * | 2.97 x |
P/E ratio 2024 * |
29.4
x | P/E ratio 2025 * |
23.8
x | Employees | 21,100 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.11% |
Latest transcript on Charles River Laboratories International, Inc.
1 day | -0.11% | ||
1 week | -1.16% | ||
Current month | +1.55% | ||
1 month | -1.43% | ||
3 months | -5.23% | ||
6 months | +23.99% | ||
Current year | -1.62% |
Managers | Title | Age | Since |
---|---|---|---|
James Foster
CEO | Chief Executive Officer | 73 | 75-12-31 |
Flavia Pease
DFI | Director of Finance/CFO | 51 | 22-04-24 |
Birgit Girshick
COO | Chief Operating Officer | 54 | 89-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
George Massaro
BRD | Director/Board Member | 76 | 02-12-31 |
Virginia Wilson
BRD | Director/Board Member | 68 | 19-09-30 |
Robert Bertolini
BRD | Director/Board Member | 61 | 11-01-24 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
3.05% | 1 M€ | -2.17% | - | |
2.07% | 5 M€ | -1.80% | - | |
1.08% | 0 M€ | 0.00% | - | |
0.98% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-15 | 232.6 | -0.11% | 529,498 |
24-05-14 | 232.8 | +1.93% | 502,307 |
24-05-13 | 228.4 | +0.13% | 447,273 |
24-05-10 | 228.1 | -0.86% | 842,499 |
24-05-09 | 230.1 | -2.21% | 1,004,419 |
Delayed Quote Nyse, May 15, 2024 at 04:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.62% | 11.98B | |
+29.77% | 49.46B | |
+1.00% | 42.58B | |
+50.47% | 42.49B | |
-5.26% | 29.09B | |
+13.68% | 26.61B | |
-22.99% | 18.64B | |
+8.22% | 13.16B | |
+32.41% | 12.55B | |
+24.01% | 12.1B |
- Stock Market
- Equities
- CRL Stock